Notice: You are viewing an unstyled version of this page. Are you using a very old browser? If so, please consider upgrading


HQIP and the funding bodies

The MBRRACE-UK collaboration, led by the National Perinatal Epidemiology Unit, University of Oxford, was appointed by the Healthcare Quality Improvement Partnership (HQIP) to undertake the Maternal, Newborn and Infant Clinical Outcome Review Programme (MNI-CORP). The initial commission for MBRRACE-UK was approved by HQIP in 2012. Further competitive re-commissioning applications were approved in 2016 and 2022. The current funding for MINI-CORP runs until the 30th September 2025.

The Healthcare Quality Improvement Partnership (HQIP) is led by a consortium of the Academy of Medical Royal Colleges and the Royal College of Nursing. Its aim is to promote quality improvement in patient outcomes. HQIP commissions, manages, supports and promotes national programmes of quality improvement including the National Clinical Audit and Patient Outcomes Programme (NCAPOP), which consists of around 40 projects including the Maternal, Newborn and Infant Clinical Outcome Review Programme (MNI-CORP). MNI-CORP is commissioned by HQIP on behalf of NHS England, the Welsh government, the Health and Social care division of the Scottish government, The Department of Health, Social Services and Public Safety, the Northern Ireland Department of Health and the States of Jersey, Guernsey and the Isle of Man.

For more details about HQIP programmes please visit hqip.org.uk/

Updated: Monday, 09 September 2024 10:31 (v7)